Jylamvo

Active Ingredient(s): Methotrexate
FDA Approved: * November 29, 2022
Pharm Company: * THERAKIND
Category: Cancer

Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune-system suppressant.[4] It is used to treat cancer, autoimmune diseases, and ectopic pregnancy and for medical abortions.[4] Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, gestational trophoblastic disease, and osteosarcoma.[4] Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Jylamvo 2 mg/ml Oral Solution
NDC: 81927-204
Labeler:
Shorla Oncology Inc.